Clinical Trial Update: Blood Pressure Effects of Nebivolol Versus Lisinopril in New Onset or Worsening Hypertension Induced by Bevacizumab [NA]

View source ↗

Summary

A clinical trial comparing nebivolol to lisinopril for new-onset or bevacizumab-induced hypertension has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Lisinopril (Lisinopril)
• Nebivolol (Nebivolol)

Snippet

Sponsor: University of Mississippi Medical Center | Conditions: Hypertension | NA | Status: WITHDRAWN